Person:
McKenna, William

Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

McKenna

First Name

William

Name

McKenna, William

Filters

20101

Settings

Author's Publications: search.filters.isAuthorOfPublication.44053358-ae53-4a17-abe0-7f89e958fef4

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Publication
    Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria
    (Ovid Technologies (Wolters Kluwer Health), 2010) Marcus, F. I.; McKenna, William; Sherrill, D.; Basso, C.; Bauce, B.; Bluemke, D. A.; Calkins, H.; Corrado, D.; Cox, M. G. P. J.; Daubert, J. P.; Fontaine, G.; Gear, K.; Hauer, R.; Nava, A.; Picard, Michael; Protonotarios, N.; Saffitz, Jeffrey; Sanborn, Danita; Steinberg, J. S.; Tandri, H.; Thiene, G.; Towbin, J. A.; Tsatsopoulou, A.; Wichter, T.; Zareba, W.
    Background: In 1994, an International Task Force proposed criteria for the clinical diagnosis of ARVC/D which facilitated recognition and interpretation of the frequently non-specific clinical features of ARVC/D. This enabled confirmatory clinical diagnosis in index cases through exclusion of phenocopies, and provided a standard upon which clinical research and genetic studies could be based. Structural, histological, electrocardiographic, arrhythmic, and familial features of the disease were incorporated into the criteria, subdivided into major and minor according to the specificity of their association with ARVC/D. At that time, clinical experience with ARVC/D was dominated by symptomatic index cases and sudden cardiac death victims: the overt and/or severe end of the disease spectrum. Consequently, the 1994 criteria were highly specific but lacked sensitivity for early and familial disease. Methods and Results: Revision of the diagnostic criteria provides guidance on the role of emerging diagnostic modalities and advances in the genetics of ARVC/D. The criteria have been modified to incorporate new knowledge and technology to improve diagnostic sensitivity, but with the important requisite of maintaining diagnostic specificity. The approach classifying structural, histological, electrocardiographic, arrhythmic, and genetic features of the disease as major and minor criteria has been maintained. In this modification of the Task Force Criteria, quantitative criteria are proposed and abnormalities are defined based on comparison with normal subject data. Conclusions: The diagnosis of ARVC/D based on modification of the original Task Force criteria is a working framework to improve the diagnosis and management of this condition.